e., (1) identify the source of tumor initiation in immunocompetent mice, and (2) systematically evaluate potential contributions of EpCAM+ and EpCAM- Hepa1-6 cells as well as the host liver cells to tumorigenesis in NASH liver. This evidence concerns the gene EPCAM and neoplasm.